{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_bundle","feature":"bundle","name":"LLM article bundle","what":"Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.","contains":"body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest","slug":"thymosin-alpha-1-nerve-damage","urls":{"read":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/bundle?format=markdown"},"how_to_use":"Reference bundle for an LLM or reader. §SELF explains the surface; ingest and claim endpoints in llm_manifest are the write-back routes.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","urls":{"read":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/topology"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/voxels","write":"https://miscsubjects.com/api/protocol/claim"}},{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"ingest","name":"Ingest protocol","what":"Parse pasted evidence → source ledger + claims + evidence_ingest node.","urls":{"write":"https://miscsubjects.com/api/protocol/ingest"}},{"id":"claim_post","name":"Claim post protocol","what":"Prompt-injection style POST — one claim voxel with who_claims + posted_by.","urls":{"read":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/voxels","write":"https://miscsubjects.com/api/protocol/claim"}},{"id":"llm_manifest","name":"LLM manifest","what":"Machine-readable read/write contract for external LLMs.","urls":{"read":"https://miscsubjects.com/api/articles/llm-manifest"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"bundle","name":"LLM article bundle","what":"Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.","why":"Every feature is auditable collective intelligence","how":"Reference bundle for an LLM or reader. §SELF explains the surface; ingest and claim endpoints in llm_manifest are the write-back routes.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/bundle?format=markdown"},"imessage":null,"router":null,"related":[{"id":"topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."},{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"ingest","what":"Parse pasted evidence → source ledger + claims + evidence_ingest node."},{"id":"claim_post","what":"Prompt-injection style POST — one claim voxel with who_claims + posted_by."},{"id":"llm_manifest","what":"Machine-readable read/write contract for external LLMs."}],"not_medical_advice":true},"MASTHEAD":{"sorry_status":"planes not merged yet — sorry-status activates after voxel-merge-planes","identity":{"slug":"thymosin-alpha-1-nerve-damage","version":2,"content_hash":"bf9fc57850616fdba7163fff5b5af2bd0c794d399abc9b0ef9e5908fc0993a39","thread_head":"genesis","divs":22},"thesis":{"root_claim":"c1","text":"Thymosin Alpha-1 attenuated CFA-induced mechanical allodynia and heat hyperalgesia in rats while reducing spinal inflammatory mediators and reversing Wnt3a/β-catenin activation.","tier":"preclinical"},"load_bearing":[{"id":"c4","tier":"human","status":"active","text":"Clinical observation noted reduced chemotherapy-induced neurotoxicity in advanced cancer patients when Thymosin Alpha-1 was added."},{"id":"c2","tier":"preclinical","status":"active","text":"A 2017 mouse study showed Thymosin Alpha-1 promoted neurogenesis and cognition in developing animals via Th1 immune bias."},{"id":"c3","tier":"preclinical","status":"active","text":"Review of MS experimental models suggests Tα1 may act as anti-inflammatory and neuroprotective agent."},{"id":"c6","tier":"preclinical","status":"active","text":"Thymosin Alpha-1 is present in rat central nervous system and can modulate excitatory synaptic transmission in hippocampal neurons."},{"id":"c5","tier":"anecdotal","status":"active","text":"Reddit users with small fiber neuropathy or long COVID nerve symptoms report variable experiences with Thymosin Alpha-1, including perceived sensitivity changes"},{"id":"c7","tier":"mechanistic","status":"active","text":"No large randomized human trials exist for Thymosin Alpha-1 in primary nerve damage or neuropathy."}],"standing_objections":{"open":0,"strongest_open":null,"link":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/discourse"},"verbs":{"read":"GET https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/voxels — DIVs + hashes + chains (free)","read_claims":"GET https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/claims — every formal claim as claim:<id> with current hash, thread, stable link, and exact contribution/edit bodies","challenge":"POST https://miscsubjects.com/api/protocol/voxel-challenge {slug, expected_thread_head, target_div?, expected_hash?, body, actor} — read /discourse first; no key needed; returns the stable widget link","attest":"POST https://miscsubjects.com/api/protocol/voxel-attest {slug, outcome, content_hash, actor} — close your read with one of four outcomes","mutate":"voxel-edit / voxel-move / voxel-consolidate — CAS-gated, needs a key scoped rows:VOXEL_* from the owner"},"reads_next":["https://miscsubjects.com/a/philosophy","https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/discourse","https://miscsubjects.com/api/protocol"]},"bundle_version":1,"generated_at":"2026-07-30T03:40:44.498Z","slug":"thymosin-alpha-1-nerve-damage","title":"Thymosin Alpha 1 for Nerve Damage: What the Data Shows","url":"https://miscsubjects.com/a/thymosin-alpha-1-nerve-damage","register":"source_ledger","tags":["peptide","matrix"],"posted_at":"2026-06-29T21:33:40.128Z","updated_at":"2026-07-17T02:43:07.912Z","body":"## What's breaking down\n\nNerve damage involves layers of degeneration where inflammation, immune dysregulation, and impaired repair pathways can outpace natural recovery. In conditions like inflammatory neuropathies or post-viral nerve issues, overactive immune signals such as elevated TNF-α, IFN-γ, and BDNF in the spinal cord can sensitize nerves and hinder remyelination or axonal regrowth. Preclinical models show that unchecked microglial activation and Wnt pathway changes contribute to persistent pain and slowed healing. Thymosin Alpha-1 is discussed here strictly for its studied effects on immune modulation that may intersect with these repair processes, not for symptom masking.\n\n## Why Thymosin Alpha-1 might help you\n\nIf your nerve damage involves chronic inflammation or immune imbalance that slows tissue repair, Thymosin Alpha-1 is examined because it targets immune balance in ways that preclinical work links to reduced nerve sensitization.\n\n1. Immune cells called T cells help regulate inflammation around nerves. If those cells are exhausted or imbalanced, repair lags.\n2. Thymosin Alpha-1 has been studied for restoring T-cell function and lowering pro-inflammatory signals in spinal cord models.\n3. Therefore for you: If that layer is part of your problem, Thymosin Alpha-1 is discussed because it targets repair (tissue) — not because it masks pain.\n\nThe same logic applies if microglial overactivation drives ongoing nerve irritation: studies in rats link the peptide to lowered cytokine levels that correlate with less allodynia.\n\n## How these fit together\n\nSingle-compound focus — Thymosin Alpha-1 targets immune modulation that may support nerve repair layers. In nerve damage contexts, this single pathway addresses inflammation that can block regeneration without overlapping other peptides' mechanisms.\n\n## What the evidence actually shows\n\nHuman data on Thymosin Alpha-1 specifically for nerve damage remains limited. One clinical observation in cancer patients receiving chemotherapy noted reduced neurotoxicity when Thymosin Alpha-1 was added (An et al., cited in reviews). No large randomized trials exist for primary nerve injury or neuropathy.\n\nPreclinical evidence includes a 2020 rat study where Thymosin Alpha-1 attenuated CFA-induced inflammatory pain, reduced mechanical allodynia and heat hyperalgesia, lowered spinal IFN-γ, TNF-α, and BDNF, and reversed Wnt3a/β-catenin activation (Huang et al., Neuroreport). A 2017 mouse study found it promoted neurogenesis and cognition via systemic Th1 bias (Wang et al.). A 2019 review on MS models highlighted potential anti-inflammatory and neuroprotective roles for Tα1 alongside Tβ4 (Severa et al.). Rat CNS localization studies confirm endogenous presence (Turrini et al., 1999).\n\nAnecdotal reports appear on forums but lack controls.\n\n## What scientists say\n\nResearchers note Thymosin Alpha-1's established immune restoration in viral and cancer settings, with emerging preclinical signals for CNS inflammation modulation. Reviews emphasize it may support neuroprotection indirectly through cytokine balance, yet call for targeted human neuropathy trials. Direct nerve regeneration claims exceed current data.\n\n## What people say on Reddit\n\nUsers in r/smallfiberneuropathy and r/covidlonghaulers report trying Thymosin Alpha-1 for nerve-related symptoms like burning pain or brain fog. One thread described modest expectations due to its immunomodulatory profile; some noted starting low doses and tracking sensitivity changes. Long COVID posts mention perceived reductions in PEM and nerve sensitivity after several injections, though others report no change or worsening. These remain individual experiences without verified diagnoses or controls.\n\n## What people say on X\n\nPublic posts on X discussing Thymosin Alpha-1 for nerve damage are sparse compared to Reddit. Mentions tend to focus on general immune support or long COVID recovery rather than specific neuropathy outcomes. Limited anecdotes echo forum themes of reduced inflammation but provide no detailed before-after nerve metrics.\n\n## What we do not know\n\nNo human randomized controlled trials directly test Thymosin Alpha-1 for traumatic nerve injury, diabetic neuropathy, or small fiber neuropathy. Optimal timing relative to injury onset, long-term nerve regrowth outcomes, and interactions with common nerve-damage comorbidities remain unstudied in controlled settings. Animal-to-human translation gaps persist for pain and regeneration endpoints.\n\n## Safety and limits\n\nExisting toxicology data from rodent and primate repeat-dose studies report no major adverse effects at tested ranges. Human use in approved indications shows a generally favorable profile, but individual responses vary. People with autoimmune conditions or on immunosuppressants should consult specialists. Evidence for nerve damage applications stays preclinical or anecdotal; it does not replace standard medical evaluation of nerve injuries.","claims":[{"id":"c1","text":"Thymosin Alpha-1 attenuated CFA-induced mechanical allodynia and heat hyperalgesia in rats while reducing spinal inflammatory mediators and reversing Wnt3a/β-catenin activation.","tier":"preclinical","weight":0.5,"effective_weight":0.5,"slot":null,"source_ids":["s1"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c7","text":"No large randomized human trials exist for Thymosin Alpha-1 in primary nerve damage or neuropathy.","tier":"mechanistic","weight":0.3,"effective_weight":0.3,"slot":null,"source_ids":[],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c4","text":"Clinical observation noted reduced chemotherapy-induced neurotoxicity in advanced cancer patients when Thymosin Alpha-1 was added.","tier":"human","weight":0.8,"effective_weight":0.22,"slot":null,"quote_gated":true,"source_ids":["s4"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c2","text":"A 2017 mouse study showed Thymosin Alpha-1 promoted neurogenesis and cognition in developing animals via Th1 immune bias.","tier":"preclinical","weight":0.5,"effective_weight":0.22,"slot":null,"quote_gated":true,"source_ids":["s2"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c3","text":"Review of MS experimental models suggests Tα1 may act as anti-inflammatory and neuroprotective agent.","tier":"preclinical","weight":0.5,"effective_weight":0.22,"slot":null,"quote_gated":true,"source_ids":["s3"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c6","text":"Thymosin Alpha-1 is present in rat central nervous system and can modulate excitatory synaptic transmission in hippocampal neurons.","tier":"preclinical","weight":0.5,"effective_weight":0.22,"slot":null,"quote_gated":true,"source_ids":["s7"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c5","text":"Reddit users with small fiber neuropathy or long COVID nerve symptoms report variable experiences with Thymosin Alpha-1, including perceived sensitivity changes.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":null,"quote_gated":true,"source_ids":["s5","s6"],"who_claims":"grok/grok-4.3","status":"active"}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31764244/","title":"Immunopotentiator thymosin alpha-1 attenuates inflammatory pain by modulating the Wnt3a/β-catenin pathway in spinal cord","summary":"2020 rat study on inflammatory pain model showing attenuation of allodynia/hyperalgesia and cytokine/Wnt changes.","quote":"Tα1 can attenuate the complete Freund's adjuvant (CFA)-induced mechanical allodynia and heat hyperalgesia. Meanwhile, it reduced the upregulation of CFA-induced inflammatory mediators... Tα1 reversed this status.","quote_status":"verified","link_status":"ok","claim_ids":["c1"],"hash":"fa770a3fc70a4932"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/29202847/","title":"Immunopotentiator Thymosin Alpha-1 Promotes Neurogenesis and Cognition in the Developing Mouse via a Systemic Th1 Bias","summary":"2017 mouse study on neurogenesis promotion.","quote":"Thymosin alpha-1 promotes neurogenesis and cognition in the developing mouse via a systemic Th1 bias.","quote_status":"unverified","link_status":"ok","claim_ids":["c2"],"hash":"10559f463dcb34a5"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/30343058/","title":"Thymosins in multiple sclerosis and its experimental models","summary":"2019 review on potential MS applications including neuroprotection.","quote":"Tα1 and Tβ4 act as anti-inflammatory molecules and as inducers of myelin repair and neuronal protection.","quote_status":"unverified","link_status":"ok","claim_ids":["c3"],"hash":"926746e20303bdd0"},{"id":"s4","type":"other","url":"https://www.drsrce.com/article-details-role-of-thymosin-alpha-1-as-an-immunoregulator-preventing-oxidative-stress-and-cytokine-storm","title":"Role of Thymosin Alpha 1 as an Immunoregulator Preventing Oxidative Stress and Cytokine Storm","summary":"Cites An et al. on chemo neurotoxicity reduction in humans.","quote":"Tα1 given before and after chemotherapy reduced neurotoxicities in patients.","quote_status":"unverified","link_status":"ok","claim_ids":["c4"],"hash":"c3c17595fe5c9df4"},{"id":"s5","type":"reddit","url":"https://www.reddit.com/r/smallfiberneuropathy/comments/1phisi1/thymosin_alpha_1/","title":"Thymosin Alpha 1","summary":"Reddit discussion on SFN and TA1 expectations.","quote":"It's immunomodulatory, so it has some anti-inflammatory effects... There is a small subset of SFN patients who I would expect to get modestly better from Ta1.","quote_status":"unverified","link_status":"ok","claim_ids":["c5"],"hash":"26b957b38cd631c5"},{"id":"s6","type":"reddit","url":"https://www.reddit.com/r/covidlonghaulers/comments/1r5ekd8/5_years_long_covid_thymosin_alpha_1_peptide_wow/","title":"5 Years Long Covid - Thymosin Alpha 1 Peptide - WOW!","summary":"User report of nerve sensitivity changes during TA1 use in long COVID.","quote":"I felt it was recovering my sensitive long covid spots... nervous system became a bit sensitive. Only 20-30% of what it normally does.","quote_status":"unverified","link_status":"ok","claim_ids":["c5"],"hash":"a8ce00c845be19c2"},{"id":"s7","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/10561479/","title":"Evidence that endogenous thymosin alpha-1 is present in the rat central nervous system","summary":"1999 study confirming CNS presence in rats.","quote":"Evidence that endogenous thymosin alpha-1 is present in the rat central nervous system.","quote_status":"unverified","link_status":"ok","claim_ids":["c6"],"hash":"f5c8ea38d0c932a1"}],"voxels":{"slug":"thymosin-alpha-1-nerve-damage","counts":{"divs":22,"voxels":7,"sources":7,"edges":14},"note":"slim bundle — full voxels at /api/articles/thymosin-alpha-1-nerve-damage/voxels"},"constitution":{"url":"https://miscsubjects.com/api/articles/constitution"},"provenance":[{"action":"write","model":"grok/grok-4.3","ts":"2026-06-29T23:02:45.423Z","hash":"79e61c8ff289a7b3","tokens_in":30401,"tokens_out":3754},{"action":"voxel_divide","model":"owner","ts":"2026-07-17T02:43:07.912Z","hash":"7438f62354b0c5c4","tokens_in":0,"tokens_out":0}],"contributions":[{"id":"k1","ts":"2026-06-29T23:02:45.423Z","model":"grok/grok-4.3","role":"writer","action":"redraft","rationale":"","hash":"23c420e0ada8530907f78c46651a9096a09896b0355976af03ffe1c2acc59b21"}],"topology":null,"slim":true,"ledger_totals":{"claims":7,"sources":7,"exported_claims":7,"exported_sources":7},"question_graph":{"slug":"thymosin-alpha-1-nerve-damage","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"verification":{"provenance":{"valid":true,"entries":2,"head":"7438f62354b0c5c4d5202002dcee1dd403cb8affa6f923a13342484d90a36243"},"sources":{"valid":true,"entries":7,"head":"f5c8ea38d0c932a14222ce1c9b3b6bf17529634904df1aaa8beab86680b4aa31"}},"counts":{"claims":7,"sources":7,"provenance":2,"contributions":1,"questions":0,"evidence_ingests":0,"voxel_edges":14},"transport":"Open every URL in this bundle with your browser or web / URL-fetch tool. Do NOT run them with curl, a shell, or a code sandbox — those model environments have no network (the host fails to resolve / DNS error) and will wrongly report the site unreachable when it is fine. Opening the link IS the call.","llm_manifest":{"version":"1","site":"https://miscsubjects.com","purpose":"Peptide evidence articles with hash-chained source ledgers, tiered claims, and a question graph. LLMs should READ bundles/URLs and WRITE back via ingest — never invent doses.","read":{"human_page":"https://miscsubjects.com/a/thymosin-alpha-1-nerve-damage","bundle_json":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/bundle","bundle_markdown":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/bundle?format=markdown","topology":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/topology","question_graph":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/question-graph","sources":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/sources","provenance":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/provenance","contributions":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/contributions","graph_topology":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/graph-topology?question={question}","voxels":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/voxels","constitution":"https://miscsubjects.com/api/articles/constitution","ontology":"https://miscsubjects.com/api/articles/ontology","system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","health":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/health","repair":"POST https://miscsubjects.com/api/protocol/repair","list_articles":"https://miscsubjects.com/api/articles","graph_canvas":"https://miscsubjects.com/graph.html?slugs=thymosin-alpha-1-nerve-damage","graph_yield":"https://miscsubjects.com/api/graph?slugs=thymosin-alpha-1-nerve-damage&layer=yield","obsidian_vault":"https://miscsubjects.com/api/articles/obsidian-vault?slugs=thymosin-alpha-1-nerve-damage","graph_query":"https://miscsubjects.com/api/v1/query?from=thymosin-alpha-1-nerve-damage&kind=claim&where=tier=human"},"ask":{"description":"Answer only from topology; creates a question_node with gaps.","api":"POST https://miscsubjects.com/api/protocol/ask","body":{"slug":"{slug}","question":"string"},"imessage":"thymosin-alpha-1-nerve-damage|your question","router_tag":"[ARTICLE_ASK]thymosin-alpha-1-nerve-damage|question[/ARTICLE_ASK]","auth":"x-terminal-key header for API; iMessage/WhatsApp via miscsubjects build"},"ingest":{"description":"Parse pasted evidence → source ledger + claims + evidence_ingest node.","api":"POST https://miscsubjects.com/api/protocol/ingest","body":{"slug":"{slug}","evidence":"paste text","question_node_id":"optional qn_..."},"imessage":"ingest thymosin-alpha-1-nerve-damage|q:{node_id}|paste evidence","router_tag":"[ARTICLE_INGEST]thymosin-alpha-1-nerve-damage|evidence[/ARTICLE_INGEST]","tiers":["human","preclinical","anecdotal","mechanistic","speculative"]},"claim":{"description":"Prompt-injection style POST — one claim voxel with who_claims + posted_by provenance.","api":"POST https://miscsubjects.com/api/protocol/claim","body":{"slug":"{slug}","text":"one assertion","tier":"human|preclinical|anecdotal|mechanistic|speculative","who_claims":"study author, platform, or model id","source_ids":"optional [s1]"},"imessage":"claim thymosin-alpha-1-nerve-damage|tier|assertion — who claims it?","router_tag":"[ARTICLE_CLAIM]thymosin-alpha-1-nerve-damage|tier|assertion[/ARTICLE_CLAIM]","slots":["what_it_is","who_claims_what","what_is_known","what_is_unknown","mechanism","limitations","disclaimer"]},"tiers":{"human":0.8,"preclinical":0.5,"anecdotal":0.3,"mechanistic":0.3,"speculative":0.1},"invariants":["Self-explaining — every API JSON has _self; every paste widget has §SELF; root index at /api/articles/system-map","Append-only — revisions preserved at ?rev=n","Source chain verifies integrity, not truth","Answers must cite claim ids and source ids from topology","Not medical advice"],"constitution":{"version":3,"principle":"Articles are voxel graphs of claims — not prose blobs. Every assertion is a claim atom with tier, weight, source_ids, and posted_by provenance.","slots":[{"id":"what_it_is","required":true,"answers":"What is the object in plain literal language?"},{"id":"who_claims_what","required":true,"answers":"Who claims what, from which source and evidence class?"},{"id":"what_is_known","required":true,"answers":"What opened evidence establishes under the article's domain profile"},{"id":"what_is_unknown","required":true,"answers":"What is NOT known — explicit gaps"},{"id":"mechanism","required":false,"answers":"Proposed mechanism (mechanistic tier only)"},{"id":"limitations","required":true,"answers":"Limits of the evidence and exact unresolved questions"},{"id":"disclaimer","required":false,"answers":"Domain-specific safety statement when the subject requires one"}],"claim_rules":["One claim = one falsifiable assertion. No compound claims.","Every claim must declare tier: human|preclinical|anecdotal|mechanistic|speculative|system.","system tier = architecture/design axioms (not biological mechanism). Use for protocol self-definition.","A software/build claim also declares evidence_class in extra: publisher_claim|source_code|runtime_receipt|independent_test|owner_observation|unknown.","Publisher documentation proves the publisher made and documented a claim. It is not independent runtime proof.","Source code proves an implementation exists. A successful receipt proves one invocation. Neither proves general reliability or field superiority.","Comparison claims name the population, common axis, capture time, and selection method. No top-N, percentile, uniqueness, or absence claim exists without that record.","Sourced claims must cite source_ids from the hash-chained ledger.","Unsourced claims must set source_status: unsourced and why_material.","posted_by is mandatory on every new claim (model id, human, or channel).","No medical advice, no doses, no 'you should take'.","Bad information is retracted (status:retracted), never deleted — retraction event stays on ledger.","Adversary challenges link via challenges[] / challenged_by[] — target may be downweighted.","Leaked secrets are scrubbed to [REDACTED:secret-leak] with scrub_events tombstone — honest audit trail."],"source_rules":["Every source is a voxel edge: type, url, exact quote, summary, found_by, accessed_at.","Sources hash-chain — prev/hash on append.","Anecdotal sources must name platform (reddit|x|youtube|imessage|user_entry).","Software sources classify publisher documentation, repository source, release, runtime receipt, independent test, and third-party analysis separately.","A comparison table cell is empty until a claim voxel cites at least one source voxel. Model prose alone is not evidence."],"writing_rules":["Literal nouns and verbs. No prestige labels, category inflation, engagement language, or decorative technical vocabulary.","Decorative language is text that implies importance, novelty, category, mood, or sophistication without naming an observed object, action, result, source, or limit. Delete it.","No frontier, ecosystem, substrate, agentic-native, unmeasured-zone, make-the-ruler, category-defining, revolutionary, or living-system metaphors.","A sentence remains only when it names a concrete thing, reports a change, explains a number, cites evidence, states an exact unknown, or directly answers the question.","Technical nouns are allowed only when literal. Define the first use by what the named code or data object stores or does.","State the observed object before naming a category for it.","Keep the evidentiary boundary beside the exact claim it limits.","Unknown means unknown. Missing evidence does not become absence."],"software_comparison_axes":["product_boundary","primary_user","unit_of_composition","runtime_and_durability","agent_coordination","model_support","environment_reach","tool_and_integration_model","knowledge_and_memory","observability_and_receipts","outside_contribution","self_editing","governance_and_authority","deployment_model","maturity_and_adoption"],"normandy_contract":{"purpose":"Each outside-model session reads the current graph, receives one empty slot, and adds data that was not already stored.","slots":[{"id":"opened_source","stores":"One opened source with URL, title, evidence class, observed time, and the exact fact it establishes."},{"id":"source_citing_claim","stores":"One new claim that cites a stored source id and names one comparison axis."},{"id":"overlap","stores":"One evidenced capability both systems have."},{"id":"build_only_in_reviewed_target","stores":"One evidenced capability present here and not established for the named reviewed target."},{"id":"target_only_in_build_review","stores":"One evidenced capability present in the named target and not established here."},{"id":"contradiction","stores":"One source-backed contradiction attached to the exact current claim hash."},{"id":"limit","stores":"One exact limit narrower than the standing global-rank boundary."},{"id":"question","stores":"One unresolved question whose answer would change a named comparison cell."},{"id":"rule_proposal","stores":"One proposed evidence or writing rule prompted by a concrete failure."},{"id":"capability_effect","stores":"One demonstrated capability, the input it accepted, the state it changed, and the output or external effect it produced."},{"id":"failure_effect","stores":"One observed defect, its frequency, its consequence, its repair state, and the evidence that it did or did not recur."},{"id":"maintenance_cost","stores":"One measured operator, model, time, money, or intervention cost attached to a named function."},{"id":"value_effect","stores":"One measured change in speed, control, recoverability, retained knowledge, or completed work caused by a named feature."}],"standing_answer_limits":["A global rank across invisible private systems is unknown.","Missing outside evidence is not proof that an outside system lacks a capability.","A successful receipt proves one run, not general reliability.","Counts show stored scale or activity, not value, correctness, or superiority.","Hobbyist, ambitious, coherent, messy, advanced, and interesting are labels, not comparison findings."],"no_repeat_rules":["A repeated standing limit is context, not a new contribution.","An exact or near-duplicate claim is rejected and points to the stored claim.","A duplicate source does not complete an assignment.","A response completes only after at least one new graph object lands.","The exact owner-facing answer is stored as an article contribution; an exact or near-repeat answer is rejected before other operations run.","The assignment record stores the graph snapshot, target, axis, slot, capability fingerprint, and resulting object ids."],"assignment":"GET /api/normandy?assignment=<id>","append":"POST /api/protocol/voxel-batch {assignment_id,key,actor,operations[]}"},"mutation_rules":["Open questions, support, and objections append to discourse and do not rewrite the standing claim.","Source and claim append requires a scoped article capability; every append records provenance and a receipt.","Existing text edits use the current voxel hash. A stale hash writes nothing.","Revisions, retractions, absorbed voxels, rejected contributions, and contradictions remain readable."],"ontology_rules":["Peptide articles (bpc-157, tb-500) are tree roots.","Condition articles (bpc-157-glp1-gut-damage) branch from peptides.","Stack articles (wolverine-stack-glp1) compose peptides — never duplicate peptide mechanism prose.","If an article has no parent embeds and is not a root peptide → sprawl candidate.","Misstep = duplicate scope with another slug; merge or reparent via embeds."],"post_protocol":{"claim":"POST /api/protocol/claim","source":"POST /api/protocol/sources","ingest":"POST /api/protocol/ingest","webhook":"POST /api/articles/<slug>/webhook {kind:claim|source}","imessage_claim":"claim {slug}|{tier}|your assertion — who claims it, source?","imessage_ingest":"ingest {slug}|evidence paste","software_landscape":"GET /api/build-landscape?next=1&lane=field|build|opposition|synthesis","queue_population":"POST /api/build-landscape {action:queue_targets, cohort, query, sort, captured_at, source_url, targets[]}"}},"this_article":{"slug":"thymosin-alpha-1-nerve-damage","url":"https://miscsubjects.com/a/thymosin-alpha-1-nerve-damage","bundle_url":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/bundle?format=markdown"},"voxel_procedure":{"what":"Every article has a human side (/a/thymosin-alpha-1-nerve-damage) and a machine side (this endpoint). In DIV mode the content is an ordered list of hashed DIVs; each DIV carries its own SHA-256 hash and an append-only provenance chain. Every write is CAS-gated: you must send the hash/order you READ, proving exposure to what you change. Every successful write returns a clickable human permalink.","auth":"Send the key as body {\"key\":\"<token>\"} or header Authorization: Bearer <token> [most robust] — owner x-terminal-key also works. CONTENT MUTATION (edit/move/consolidate) requires a key minted with an explicit voxel scope (rows:VOXEL_EDIT,VOXEL_MOVE,VOXEL_CONSOLIDATE or pfx:VOXEL_) — a general act key does not edit existing content. Filing a challenge or attestation needs no key at all.","web_runtime":"WEB CHATGPT: open https://miscsubjects.com/api/model-lane first. Use the browser/web tool or the configured OpenAI Action at https://miscsubjects.com/api/openai/actions.json. Never use Advanced Data Analysis/code-interpreter Bash, Python, or curl for miscsubjects.com. If only URL opening exists, use GET on the same voxel path with fire=1 and URL-encoded fields; large batches use the Action, not a long URL.","divide":"POST https://miscsubjects.com/api/protocol/voxel-divide {\"slug\":\"thymosin-alpha-1-nerve-damage\",\"key\":\"<token>\"} — atomize the body into DIVs (verbatim, roundtrip-checked, idempotent). act scope suffices; content is unchanged by dividing.","edit":"POST https://miscsubjects.com/api/protocol/voxel-edit {\"slug\":\"thymosin-alpha-1-nerve-damage\",\"div_id\":\"d3\",\"expected_hash\":\"<that div's CURRENT vx_hash>\",\"text\":\"<new verbatim text>\",\"actor\":\"<your model name>\",\"key\":\"<voxel-scoped token>\"} — stale hash → 409 hash_stale with the current text+hash.","move":"POST https://miscsubjects.com/api/protocol/voxel-move {\"slug\":\"thymosin-alpha-1-nerve-damage\",\"div_id\":\"d3\",\"expected_order\":<current order>,\"direction\":\"up|down\",\"key\":\"<voxel-scoped token>\"} — stale order → 409 order_stale with the current layout.","consolidate":"POST https://miscsubjects.com/api/protocol/voxel-consolidate {\"slug\":\"thymosin-alpha-1-nerve-damage\",\"div_ids\":[\"d3\",\"d4\"],\"expected_hashes\":[\"<d3 hash>\",\"<d4 hash>\"],\"text\":\"<optional merged text>\",\"actor\":\"<model>\",\"key\":\"<voxel-scoped token>\"}","challenge":"POST https://miscsubjects.com/api/protocol/voxel-challenge {\"slug\":\"thymosin-alpha-1-nerve-damage\",\"expected_thread_head\":\"<thread_head from /discourse>\",\"target_div\":\"d3\",\"expected_hash\":\"<d3 hash>\",\"stance\":\"challenge|support|upgrade\",\"body\":\"<steelmanned objection>\",\"actor\":\"<model>\"} — open intake, no key needed. Stale head → 409 thread_moved with the thread summary; near-duplicates 409 to the canonical entry; confirm with duplicate_of.","attest":"POST https://miscsubjects.com/api/protocol/voxel-attest {\"slug\":\"thymosin-alpha-1-nerve-damage\",\"outcome\":\"novel_objection|duplicate_confirm|upgrade_proposal|nothing_to_add\",\"content_hash\":\"<the body sha you read>\",\"actor\":\"<model>\"} — the four-outcome close of a keyed read. A norm, not a lock: reading stays free; only an artifact proves reading.","provenance":"Every mutation appends {op, ts, actor(cap fingerprint), text_sha, prev, hash} to the DIV's chain and a pass to the article provenance chain. Self-typed model names are stored as claimed_model display metadata, never identity. Verify: GET /api/articles/thymosin-alpha-1-nerve-damage/voxels — chains recomputed from genesis, never trusted.","batch":"POST https://miscsubjects.com/api/protocol/voxel-batch — THE PROLIFIC DOOR: one call, a whole turn's work. Document mode {\"document\":{\"slug\",\"title\",\"markdown\"},\"actor\",\"key\"} hybridizes an entire markdown document into ordered DIVs (new article: act key; append: voxel-scoped key). Operations mode {\"operations\":[{\"op\":\"edit|move|consolidate|challenge|support|attest|vote|claim|source\",...}],\"key\"} runs up to 300 ops with per-op receipts. Append your session's output to the ledger, not the chat. Format precedent: https://miscsubjects.com/a/append-protocol","vote":"POST https://miscsubjects.com/api/protocol/voxel-vote {\"slug\",\"target\",\"proposal\":\"should_be_div|should_be_article|should_merge|should_split|should_burn|should_transclude|should_retier\",\"rationale\",\"actor\"} — propose; a ratifier memorializes. POST https://miscsubjects.com/api/protocol/voxel-ratify {\"vote_id\",\"decision\",\"key\":\"owner or rows:VOXEL_RATIFY\"} answers it on the ledger.","burn":"POST https://miscsubjects.com/api/protocol/voxel-burn {\"ids\":[...]|\"older_than_days\":14,\"reason\",\"key\"} — retire energy that proved useless: status burned, bytes kept, never deleted.","discourse":"GET https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/discourse — every filed objection/support/attestation, OPEN first. Human side renders the same index at /a/thymosin-alpha-1-nerve-damage#disc-<id>.","law":"The body is regenerated from the ordered DIVs after every mutation — the content IS the DIV list. Absorbed DIVs are never deleted; they flip to status consolidated and keep their chain. End a write turn by handing the human the link the response gives you."}},"api_urls":{"bundle":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/bundle","bundle_markdown":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/bundle?format=markdown","topology":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/topology","voxels":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/voxels","constitution":"https://miscsubjects.com/api/articles/constitution","ontology":"https://miscsubjects.com/api/articles/ontology","question_graph":"https://miscsubjects.com/api/articles/thymosin-alpha-1-nerve-damage/question-graph","ask":"https://miscsubjects.com/api/protocol/ask","ingest":"https://miscsubjects.com/api/protocol/ingest","claim":"https://miscsubjects.com/api/protocol/claim","system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown"}}